First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

E

Educator

New member
The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
 
You must log in or register to reply here.
Menu
Log in
Register